Table 1.
Physiological causes of hypoglycemia | Chief mechanism or mechanisms |
---|---|
Extreme exercise (e.g., hunting dog hypoglycemia) | Excess glucose utilization and inadequate glycogen stores |
Neonatal/juvenile or toy breed juvenile hypoglycemia | Inadequate glycogen stores, limited fat and muscle mass |
Malnutrition/starvation | Inadequate intake and depletion of glycogen stores |
Drug and toxin associated causes such as iatrogenic insulin overdose, xylitol toxicity, oral hypoglycemic agents (usually sulfonylureas), beta blockers | Excess glucose utilization due to hypersecretion of insulin and increased tissue sensitivity to insulin. Beta blockers via suspected interference of counter- regulatory mechanisms |
| |
Pathological causes of hypoglycemia | |
| |
Severe hepatic disease such as hepatitis, cirrhosis, neoplasia, amyloidosis, hepatotoxins | Decreased hepatic gluconeogenesis |
Congenital portosystemic shunt | Decreased hepatic gluconeogenesis |
Hypoadrenocorticism | Decreased glucose production from lack of a counter-regulatory hormone (i.e., cortisol) |
Hypopituitarism | Decreased glucose production from lack of a counter-regulatory hormone (i.e., growth hormone or adrenocorticotropic hormone) |
Insulinoma | Excess glucose utilization due to hypersecretion of insulin |
Islet cell hyperplasiaa | Excess glucose utilization due to hypersecretion of insulin |
Extra-pancreatic tumors (e.g., hepatocellular carcinoma, hepatoma, leiomyosarcoma, leiomyoma) | Increased glucose utilization by the tumor but also due to secretion of insulin analogues |
Chronic renal failure | Decreased hepatic gluconeogenesis |
Pancreatitis | Unknown |
Infection (e.g., sepsis, severe canine babesiosis) | Decreased hepatic glycogenesis and increased glucose utilization |
Glycogen storage disease | Deficiency of enzymes required for glycogen conversion |
| |
Artifactual/spurious | Laboratory error from improper sample handling or submission, use of a human glucometer, leukemia/polycythemia vera |
Reported as a rare cause of hypoglycemia in humans.
This pancreatic pathology has been documented in dogs but without hyperinsulinemic hypoglycemia syndrome.